Pacira Belgium
0742.926.265 · rovalta.com · 26/09/2026
Pacira Belgium
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOPacira Belgium is a Private limited company incorporated in 2020. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Eupen. It employs on average 1,3 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0742.926.265
- Incorporation
- 05/02/2020
- Legal form
- Private limited company
- Registered office
- Industriestrasse 38
4700 Eupen · WallonieSee on map - Contributed capital
- 1 800 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 1,3 ETP
Financials
Source · NBB, 6 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 191,1 k € | -21.8% | 244,2 k € | -21.2% | 310 k € | -0.2% | 310,6 k € | -29.4% | 440,3 k € |
| EBITDA | 25,9 k € | -32.8% | 38,5 k € | -3.0% | 39,7 k € | -45.7% | 73,1 k € | -23.1% | 95,1 k € |
| Operating result | 3,7 k € | -90.5% | 38,5 k € | -1.2% | 39 k € | -45.5% | 71,5 k € | -20.2% | 89,5 k € |
| Net result | -1,7 k € | -107% | 24 k € | +0.1% | 23,9 k € | -57.1% | 55,8 k € | +29.5% | 43,1 k € |
| Balance sheet | |||||||||
| Equity | 1,9 M € | -0.1% | 1,9 M € | +1.2% | 1,9 M € | +1.3% | 1,9 M € | +3.0% | 1,8 M € |
| Total assets | 3 M € | +4.8% | 2,9 M € | +1.0% | 2,8 M € | +3.2% | 2,7 M € | -45.3% | 5 M € |
| Cash | 139,2 k € | +90.4% | 73,1 k € | -86.2% | 530,6 k € | -58.8% | 1,3 M € | -48.6% | 2,5 M € |
| Debts | 1 M € | +12.9% | 917,6 k € | +0.4% | 914,2 k € | +7.5% | 850,3 k € | -73.3% | 3,2 M € |
| Other | |||||||||
| Workforce | 1,3 ETP | -13.3% | 1,5 ETP | -25.0% | 2,0 ETP | 0.0% | 2,0 ETP | +53.8% | 1,3 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20254 active
Active mandates
Other companies at this address
Industriestrasse 38 4700 Eupen| Company | CBE no. |
|---|---|
BRANDS4YOU● Active | 0500.996.882 |
BUSKES● Active | 0416.948.263 |
Drops And More● Active | 0679.818.065 |
Escapade● Active | 0664.807.118 |
FORUM EUPEN● Active | 0875.430.641 |
ICONV● Active | 0880.533.435 |
IMMOBILIERE D'EUPEN● Active | 0429.516.790 |
ISZALY PRINT SOLUTIONS● Active | 1033.926.463 |
KIBO● Active | 0793.283.123 |
LANVISION● Liquidation | 0873.672.367 |
PLUS MANAGEMENT● Active | 0894.526.377 |
PLUS PHARMA● Active | 0811.970.964 |
ROM● Active | 0441.826.783 |
SCHUSTER & CAMBRIA G.m.b.H.● Liquidation | 0534.884.130 |
| 1035.218.939 | |
VILLA ROMANA● Active | 0866.321.648 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 05/02/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 23 months |
| Filing date | 01/07/2026 | 11/07/2025 | 14/06/2024 | 14/06/2023 | 29/07/2022 |
| General meeting | 30/06/2026 | 08/07/2025 | 16/05/2024 | 18/05/2023 | 20/05/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 01/07/2026 | German | |
| Abridged model | 31/12/2024 | 08/07/2025 | 11/07/2025 | German | |
| Abridged model | 31/12/2023 | 16/05/2024 | 14/06/2024 | German | |
| Abridged model | 31/12/2022 | 18/05/2023 | 14/06/2023 | German | |
| Abridged modelCorrection | 31/12/2021 | 20/05/2022 | 29/07/2022 | German | |
| Abridged model | 31/12/2021 | 20/05/2022 | 23/06/2022 | German |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20254 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-1,7 k €↓
- 2024Annual accounts 202424 k €↑
- 2024Name changePacira Belgium GmbH
- 2023Annual accounts 202323,9 k €↓
- 2022Annual accounts 202255,8 k €↑
- 2022Name changeGQ Bio Therapeutics Belgium
- 2021Annual accounts 202143,1 k €
- 2021Name changeGeneQuine Biotherapeutics Belgium
- 05/02/2020IncorporationPrivate limited company